Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Equity (2016 - 2025)

Assembly Biosciences has reported Return on Equity over the past 11 years, most recently at 0.03% for Q4 2025.

  • Quarterly results put Return on Equity at 0.03% for Q4 2025, up 132.0% from a year ago — trailing twelve months through Dec 2025 was 0.03% (up 132.0% YoY), and the annual figure for FY2025 was 0.05%, up 103.0%.
  • Return on Equity for Q4 2025 was 0.03% at Assembly Biosciences, up from 0.38% in the prior quarter.
  • Over the last five years, Return on Equity for ASMB hit a ceiling of 0.03% in Q4 2025 and a floor of 1.72% in Q2 2025.
  • Median Return on Equity over the past 5 years was 1.17% (2023), compared with a mean of 1.0%.
  • Biggest five-year swings in Return on Equity: tumbled -70bps in 2022 and later surged 132bps in 2025.
  • Assembly Biosciences' Return on Equity stood at 0.67% in 2021, then tumbled by -50bps to 1.01% in 2022, then tumbled by -47bps to 1.48% in 2023, then increased by 8bps to 1.35% in 2024, then soared by 98bps to 0.03% in 2025.
  • The last three reported values for Return on Equity were 0.03% (Q4 2025), 0.38% (Q3 2025), and 1.72% (Q2 2025) per Business Quant data.